OHSU Cancer Institute researchers find novel chemo drug helps treat prostate cancer
Men with a certain type of prostate cancer have been shown to respond to a new chemotherapy drug, Sagopilone, plus prednisone in an international trial led by Oregon Health & Science University Cancer Institute researchers. The research involved men with androgen-independent prostate cancer that has metastasized, meaning their cancer has spread beyond the prostate and is not longer responding to hormonal therapies. This is the most advanced form of prostate cancer. Prostate cancer is the most common type of cancer in men in the United States, where it is responsible for more male deaths than any other cancer, except lung cancer.
"We are showing solid activity that this drug shows promise," said Tomasz Beer, M.D., principal investigator. He is the Grover C. Bagby Endowed Chair for Cancer Research, director of the Prostate Cancer Research Program at the OHSU Cancer Institute and associate professor of medicine (hematology/medical oncology), OHSU School of Medicine.
This research will be presented Saturday, May 31 at 8 a.m. at the annual American Association of Clinical Oncology in Chicago.
Of the 37 study participants taking the Sagopilone and prednisone long enough to be evaluated, the majority showed positive results in the reduction of their prostate specific antigens, or PSA. PSA is often elevated in the presence of prostate cancer.
During the three-month trial thirteen study participants had a more than 50 percent reduction in their PSA; 23 showed a 30 percent reduction; one who had radiographic measurable disease showed complete response; and four had unconfirmed prostate response. A 30 percent reduction in PSA levels in three months is a strong indicator of survival.
Sagopilone, a fully synthetic derivation, is a new class of drug that inhibits growth and the spread of malignant cell, similar to docetaxel, which has been the gold standard for this type of hormone independent prostate cancer. Docetaxel, however, it is not a cure and not all patients benefit from it. For this reason, Beer and colleagues are committed to searching for new drugs that will be effective against advanced prostate cancer.
"We look forward to completing this study and to the further investigation of Sagopilone as a new treatment option for men with advanced prostate cancer," said Beer.
Source: Oregon Health & Science University
Articles on the same topic
- OHSU Cancer Institute finds that drug stimulated immune system in prostate cancerMon, 2 Jun 2008, 18:14:53 UTC
- Blocking signaling protein prevents prostate cancer spread, Jefferson scientists findMon, 2 Jun 2008, 13:22:03 UTC
- How advanced prostate cancer becomes resistant to androgen-deprivation therapySun, 1 Jun 2008, 4:43:08 UTC
- Certain form of tomatoes could be key to prostate cancer preventionThu, 29 May 2008, 19:36:03 UTC
- Dehydrated tomatoes show promise for preventing prostate cancerThu, 29 May 2008, 4:21:56 UTC
- No association found between vitamin D concentration in blood and risk of prostate cancerTue, 27 May 2008, 20:28:46 UTC
- Monitoring blood flow helps improve prostate biopsies, Jefferson researchers reportSat, 24 May 2008, 20:28:31 UTC
Other sources
- Blocking Signaling Protein Prevents Prostate Cancer Spread, Scientists Findfrom Science DailyThu, 5 Jun 2008, 0:35:41 UTC
- Drug Found To Stimulate Immune System In Patients With Prostate Cancerfrom Science DailyTue, 3 Jun 2008, 3:14:40 UTC
- Scientists find that drug stimulated immune system in prostate cancerfrom PhysorgMon, 2 Jun 2008, 19:21:45 UTC
- Blocking signaling protein prevents prostate cancer spreadfrom PhysorgMon, 2 Jun 2008, 14:49:11 UTC
- Dehydrated Tomatoes Show Promise For Preventing Prostate Cancerfrom Science DailyMon, 2 Jun 2008, 3:14:22 UTC
- Novel Chemo Drug Helps Treat Prostate Cancerfrom Science DailyFri, 30 May 2008, 22:21:08 UTC
- Men with prostate cancer risk fracturesfrom Science AlertThu, 29 May 2008, 22:14:08 UTC
- Dehydrated tomatoes show promise for preventing prostate cancerfrom Science BlogThu, 29 May 2008, 12:56:10 UTC
- Dehydrated tomatoes show promise for preventing prostate cancerfrom PhysorgThu, 29 May 2008, 10:21:21 UTC
- No association found between vitamin D concentration in blood and risk of prostate cancerfrom PhysorgTue, 27 May 2008, 21:56:17 UTC
- Monitoring blood flow helps improve prostate biopsies, researchers reportfrom PhysorgSat, 24 May 2008, 20:28:05 UTC